Trial evaluates 2 dose schedules for LY3209590 in comparison to daily insulin Degludec
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.
Study Length: 26 Weeks
Target Age/Sex: over 18 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures